Feb 28 |
Q4 2023 Kura Oncology Inc Earnings Call
|
Feb 28 |
Kura Oncology, Inc. (KURA) Q4 2023 Earnings Call Transcript
|
Feb 28 |
Kura Oncology, Inc. 2023 Q4 - Results - Earnings Call Presentation
|
Feb 27 |
Kura Oncology Inc (KURA) Reports Q4 and Full Year 2023 Financial Results
|
Feb 27 |
Kura Oncology GAAP EPS of -$0.55 in-line
|
Feb 27 |
Kura Oncology Reports Fourth Quarter and Full Year 2023 Financial Results
|
Feb 26 |
Kura Oncology FY 2023 Earnings Preview
|
Feb 26 |
Kura Oncology Doses First Patient in KOMET-008 Trial of Ziftomenib in Combination with Standards of Care, Including FLT3 Inhibitor, in Acute Myeloid Leukemia
|
Feb 22 |
Kura Oncology to Participate in Three Upcoming Investor Conferences
|
Feb 20 |
Kura Oncology to Report Fourth Quarter and Full Year 2023 Financial Results
|